SAURABH SAHU
@nishikant.8346
Bhopal
5+ Years of experience
SEBI Registration INH000014322Saurabh Sahu, the founder of AFS Trading Edge, is a seasoned trader and market expert committed to empowering investors with the tools and insights needed to succeed in the financial markets. Through this community, Saurabh shares daily market trends, momentum strategies, and expert trading tips to help traders stay ah ... Read more
Trade Ideas
466
Opinions
929
Followers
125k
Expertise
Quantitative
Growth
Technical
Index Strategies
Swing Trading
Market Commentary
Futures & Options
Technical Analysis
Trade Facts
Total Trades
0
Missed Trades
0
Profit Trades
0
0%Accuracy
Ask me Anything
Got a question? Ask me and I will answer it. Stay curious, stay hungry!
Posts
shared an insight ⚡️ 14th Aug
📊 Amber Enterprises Q1 FY27: Strong Operational Performance 🚀
Amber Enterprises India Ltd. reported a solid Q1 FY27 performance, with profitability growing faster than revenue.
🔹 Revenue: ₹3,888 Cr | +13% YoY
🔹 Operating EBITDA: ₹337 Cr | +28% YoY
🔹 Adjusted PAT: ₹126 Cr | +19% YoY
📌 Key Highlights:
• Consumer Durables revenue grew 8%, EBITDA 12%
• Electronics revenue surged 29%, while EBITDA jumped 117% 🚀
• Railway Sub-systems & Defence revenue increased 18%, but EBITDA declined 26%
🔥 Future Growth Triggers:
Amber is entering mobile phone manufacturing through a collaboration with OPPO Mobiles India. The company has also commenced development of an HDI PCB manufacturing facility at Jewar, Uttar Pradesh, in collaboration with Korea Circuit.
Investor View:
The strong Electronics division and improving operating profitability are positive signals. However, investors should monitor the Railway & Defence EBITDA decline and the impact of exceptional items.
📈 Overall: Positive Q1 with strong electronics momentum and promising diversification opportunities.
Source: Company Press Release | Q1 FY27
Disclaimer: This post is for educational/informational purposes only and is not investment advice. Please conduct your own research before making investment decisions.
AMBER
shared an insight ⚡️ 13th Aug
Tata Motors Passenger Vehicles: Q1 FY27 — Strong India Growth, JLR Under Pressure
🚗 **Tata Motors Passenger Vehicles** delivered a mixed Q1 FY27 performance, with strong momentum in the India PV/EV business offsetting weakness at Jaguar Land Rover (JLR).
### 📊 Consolidated Performance
* **Revenue:** ₹95,799 Cr, up **9.3% YoY**
* **EBITDA:** ₹7,128 Cr; margin **7.4%**
* **PBT:** ₹1,606 Cr
* **EBIT margin:** **2.4%**
* **Net debt:** ₹42,200 Cr
### 🇮🇳 Tata PV — Strong Growth
The India passenger vehicle business recorded **182K+ wholesale volumes**, up **46% YoY**, while market share strengthened to **14.3%**. EV volumes crossed **34K units**, with EV market share around **40%**.
EV momentum remains particularly strong, with EV volumes up **112% YoY** and the company maintaining market leadership despite increasing competition.
### 🌍 JLR — Key Weak Spot
JLR reported:
* Revenue of **£6.0bn**, down **9.6% YoY**
* Adjusted EBIT margin of **2.8%**, versus 4.0% YoY
* PBT before exceptional items of **£109m**, versus £351m
* Free cash flow of **-£998m**
Temporary supply constraints, Middle East disruption, Jaguar model transition and higher market-related costs affected performance.
### 🔎 Investor Takeaway
The quarter highlights a clear **two-speed story**: Tata’s India PV and EV business is gaining market share rapidly, while JLR remains the major earnings and cash-flow challenge.
The next key monitorables are **JLR's new product launches, supply-chain normalization, margin recovery and Tata PV's ability to convert strong volumes into higher profitability**.
Disclaimer:** This content is for informational purposes only and is not investment advice.
TMPV
shared an insight ⚡️ 13th Aug
Max Healthcare Q1 FY27: Strong Revenue Growth, Expansion Sets the Stage for the Next Leg 📊🏥
Max Healthcare Institute Ltd. (MAXHEALTH) delivered a strong start to FY27, with revenue growth remaining robust and operating performance broadly healthy.
📌 Q1 FY27 Key Highlights
🔹 Gross Revenue: ₹2,982 Cr | +16% YoY
🔹 Net Revenue: ₹2,835 Cr | +15% YoY
🔹 Operating EBITDA: ₹704 Cr | +15% YoY
🔹 EBITDA Margin: 24.8% vs 24.9% YoY
🔹 PAT: ₹357 Cr | +3% YoY
🔹 Free Cash from Operations: ₹397 Cr
🔹 ARPOB: ₹81.9K | +5% YoY
🔹 Occupancy: 75%
🔹 Occupied Bed Days: +10% YoY
🚀 Growth Drivers
Max Healthcare added 630 net beds over the last 12 months, taking operational capacity to 5,379 beds as of June 2026. Additional brownfield capacity is expected to come online, supporting future revenue growth.
The company also completed the acquisition of 58.28% of Kalinga Hospital and acquired Class A shares of Yerawada Properties, supporting its expansion into Bhubaneswar and Pune.
International patient revenue grew 18% YoY to ₹247 Cr, while Max Lab and Max@Home continued to grow strongly.
⚠️ What Investors Should Watch
PAT growth of 3% was considerably slower than revenue and EBITDA growth, mainly because of higher depreciation and finance costs following capacity expansion.
Net debt increased to ₹2,384 Cr from ₹1,908 Cr in March 2026, reflecting acquisitions and ongoing expansion.
🔍 Our View
Operationally positive. Revenue, EBITDA, patient volumes and ARPOB all moved in the right direction. The near-term margin pressure and higher debt need monitoring, but the increasing bed capacity, acquisitions and strong cash generation provide multiple avenues for long-term growth.
📈 Investor Takeaway: Positive for long-term growth; monitor debt, margins and occupancy during the expansion phase.
Disclaimer: This content is for educational purposes only and is not investment advice. Please conduct your own research or consult a SEBI-registered investment professional before making investment decisions.
MAXHEALTH
FAQ's
What are the top stock recommendations by SAURABH SAHU?
SAURABH SAHU regularly shares stock views and market analysis on StockGro. Some of the stocks they have recently shared views on include Larsen and Toubro Ltd (Bullish), ICICI Bank Ltd (Bullish), AMBER, TMPV and MAXHEALTH. Explore SAURABH SAHU's complete list of posts and trade views on their StockGro profile.
How can I follow SAURABH SAHU's latest investment insights?
You can follow SAURABH SAHU's latest investment insights, stock recommendations, and market analysis on StockGro App. Additionally, you can check their detailed stock analysis reports in the StockGro blog section.
What is SAURABH SAHU's investment strategy?
SAURABH SAHU follows a data-driven, research-backed investment strategy focused on maximizing returns while managing risk. Their approach includes fundamental and technical analysis, portfolio diversification, and sectoral trends to identify high-potential stocks.
How long has SAURABH SAHU been a SEBI-registered Research Analyst (RA)?
SAURABH SAHU has been a SEBI-registered Research Analyst and have 5+ Years of experience. With extensive experience in stock market analysis and investment research, they have guided investors in making informed and profitable decisions.
Where can I see SAURABH SAHU's past performance and stock picks?
You can check SAURABH SAHU's past stock recommendations, success rate, and investment insights on their StockGro profile. Their historical stock picks reflect a track record of strategic investment decisions based on thorough research.
How can I contact SAURABH SAHU for stock market advice?
For stock market guidance from SAURABH SAHU, you can connect through their StockGro profile. Some RAs may also provide personalized investment consultations based on their availability and SEBI regulations.
What is SAURABH SAHU's track record in predicting market movements?
SAURABH SAHU has a proven track record of accurate market analysis and trend predictions. By analyzing economic indicators, market sentiment, and technical charts, they have consistently helped investors make well-timed investment decisions.
What is the SEBI Registration number for SAURABH SAHU?
SAURABH SAHU is a SEBI-registered Research Analyst with the SEBI Registration INH000014322. This ensures that their investment recommendations comply with SEBI's regulatory framework for investor protection and financial advisory standards.
Be Financially Free with StockGro